Andrew Rodriguez is a process and analytical chemist at Ionis Pharmaceuticals where he has worked for the last 10 years optimizing the manufacture and analysis of oligonucleotide therapeutics. He earned his Ph.D. from UC Irvine in organic chemistry studying living polymerization and organocatalytic reactions.